Biodexa Pharmaceuticals Plc Is A Clinical Stage Biopharmaceutical Company Based In The Ukdedicated To Developing Treatments For Diseases With Significant Unmet Clinical Needssuch As Cancers And Metabolic Disordersfounded In 2000 And Incorporated As A Public Company In 2014Biodexa Is Headquartered In Cardiffwalesand Is Publicly Traded Under The Ticker Bdrx The Company Focuses On Research And Experimental Development In Biotechnologyutilizing Innovative Technologies Like The Q Sphera Platform For Sustained Release Drug Deliverymidasolve For Solubilizing Poorly Soluble Drugsand Midacore For Targeted Delivery Using Gold Nanoparticlesbiodexa S Pipeline Includes Investigational Treatments Such As Mtx110 For Brain Cancersmtd201 For Acromegaly And Neuroendocrine Tumorsand Mtd211 For Schizophrenia And Major Depressive Disorderthe Company Collaborates With Partners Like Janssen And Melior To Advance Its Drug Development Efforts
